Ultrasensitive detection of unknown colon cancer-initiating mutations using the example of the Adenomatous Polyposis Coli gene

Cancer Prevention Research

Volumn 6, Issue 9, 2013, Pages 898-907

  Gerecke, Christian ^a   Mascher, Conny ^a   Gottschalk, Uwe ^b   Kleuser, Burkhard ^a   Scholtka, Bettina ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

^b Abteilung Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

APC GENE; ARTICLE; CANCER GENETICS; COLON CANCER; DNA DETERMINATION; GENE; GENE MUTATION; GENETIC ANALYSIS; HIGH RESOLUTION MELTING ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI PROTEIN; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMERASE CHAIN REACTION;

EID: 84883779712     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0145     Document Type: Article

References (34)

1. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
3. Chan TL, Zhao W, Leung SY, Yuen ST. B-RAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003;63:4878-81.
4. Scholtka B, Schneider M, Melcher R, Katzenberger T, Friedrich D, Berghof-Jäger K, et al. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans. Cancer Epidemiol 2009;33:123-9.
5. Schneider M, Scholtka B, Gottschalk U, Faiss S, Schatz D, Berghof-Jäger K, et al. Detection of up to 65% of precancerous lesions of the human colon and rectum by mutation analysis of APC, KRAS, B-Raf and CTNNB1. Cancers 2011;3:91-105.
6. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
7. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70. (Pubitemid 26358996)
8. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, et al. Somatic APC and KRAS Codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994;54:5527-30. (Pubitemid 24346239)
9. Yuan P, Sun MH, Zhang JS, Zhu XZ, Shi DR. APC and KRAS gene mutation in aberrant crypt foci of human colon. World J Gastroenterol 2001;7:352-6. (Pubitemid 32586519)
10. Fearon ER, Vogelstein B.A genetic model for colorectal tumorigenesis. Cell 1998;61:759-67.
11. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. B-RAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004;28:1452-9.
12. Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, et al. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 2001;8:255-60.
13. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 2006;49:121-31. (Pubitemid 44079695)
14. Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T. β-Catenin and ras oncogenes detect most human colorectal cancer. Clin Cancer Res 2003;9:3073-9. (Pubitemid 36993270)
15. Fransén K, Klintenäs M, Osterström A, Dimberg J, Monstein HJ, Söderkvist P. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 2004;25:527-33. (Pubitemid 38528645)
16. Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, et al. Mutations in APC, CTNNB1 and KRAS genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer 2005;5:160-70.
17. Suraweera N, Robinson J, Volikos E, Guenther T, Talbot I, Tomlinson I, et al. Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int J Cancer 2006;119:1837-42. (Pubitemid 44356840)
18. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
19. Traverso G, Shuber AP, Levin B, Johnson C, Olsson L, Schoetz DJ, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-20. (Pubitemid 34438838)
20. Klaassen CH, Jeunink MA, Prinsen CF, Ruers TJ, Tan AC, Strobbe LJ, et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem 2003;49:1185-7. (Pubitemid 36751108)
21. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992;1:229-33.
22. Cheadle JP, Krawaczak M, Thomas MW, Hodges AK, Al-Tasan N, Fleming N, et al. Different combinsations of biallelic APC mutatin confer different growth advantages in colorectal tumours. Cancer Res 2002;62:363-6. (Pubitemid 34106404)
23. Muniappan BP, Thilly WG. The DNA polymerase beta replication error spectrum in the adenomatous polyposis coli gene contains human colon tumor mutational hotspots. Cancer Res 2002;62:3271-5. (Pubitemid 34602424)
24. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 2000;97:3352-7. (Pubitemid 30183306)
25. Steinberg P, Scholtka B, inventors; Universitaet Potsdam, assignee. Method for conducting non-invasive early detection of colon cancer and/or of colon cancer precursor cells. United States Patent US 7,833,757 B2. 2010 Nov 16.
26. Efrati E, Elkin H, Peerless Y, Sabo E, Ben-Izhak O, Hershkovitz D. LNA-based PCR clamping enrichment assay for the identification of KRAS mutations. Cancer Biomark 2010/2011;8:89-94.
27. Do H, Dobrovic A. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low-level mutations in cancer biopsies. Mol Cancer 2009;8:82.
28. Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, et al. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer 2011;11:406.
29. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, et al. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 2009;136:459-70.
30. Thomas RK, Nickerson E, Simons JF, Jänne PA, Tengs T, Yuza Y, et al. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. N Engl J Med 2006;350:2129-39.
31. Milbury CA, Li J, Makrigiorgos GM. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem 2009;55:2130-43.
32. Milbury CA, Li J, Makrigiorgos GM. PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem 2009;55:632-40.
33. McTigue PM, Peterson RJ, Kahn JD. Sequence-dependent thermodynamic parameters for locked nucleic acid (LNA)-DNA duplex formation. Biochemistry 2004;43:5388-405. (Pubitemid 38620931)
34. You Y, Moreira BG, Behlke MA, Owczarzy R. Design of LNA probes that improve mismatch discrimination. Nucleic Acids Res 2006;34:e60.